Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial von Wilding, J. P. H., Charpentier, G., Hollander, P., González-Gálvez, G., Mathieu, C., Vercruysse, F., Usiskin, K., Law, G., Black, S., Canovatchel, W., Meininger, G.

Volltext

Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study von Franc, S., Daoudi, A., Pochat, A., Petit, M.-H., Randazzo, C., Petit, C., Duclos, M., Penfornis, A., Pussard, E., Not, D., Heyman, E., Koukoui, F., Simon, C., Charpentier, G.

Volltext

Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population von Robiou-du-Pont, S, Bonnefond, A, Yengo, L, Vaillant, E, Lobbens, S, Durand, E, Weill, J, Lantieri, O, Balkau, B, Charpentier, G, Marre, M, Froguel, P, Meyre, D

Volltext

Practical implementation of automated closed-loop insulin delivery: A French position statement von Tubiana-Rufi, N., Schaepelynck, P., Franc, S., Chaillous, L., Joubert, M., Renard, E., Reznik, Y., Abettan, C., Bismuth, E., Beltrand, J., Bonnemaison, E., Borot, S., Charpentier, G., Delemer, B., Desserprix, A., Durain, D., Farret, A., Filhol, N., Guerci, B., Guilhem, I., Guillot, C., Jeandidier, N., Lablanche, S., Leroy, R., Melki, V., Munch, M., Penfornis, A., Picard, S., Place, J., Riveline, J.P., Serusclat, P., Sola-Gazagnes, A., Thivolet, C., Hanaire, H., Benhamou, P.Y.

Volltext

Earlier triple therapy with pioglitazone in patients with type 2 diabetes von Charpentier, G, Halimi, S

Volltext

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement von Borot, S., Benhamou, P.Y., Atlan, C., Bismuth, E., Bonnemaison, E., Catargi, B., Charpentier, G., Farret, A., Filhol, N., Franc, S., Gouet, D., Guerci, B., Guilhem, I., Guillot, C., Jeandidier, N., Joubert, M., Melki, V., Merlen, E., Penfornis, A., Picard, S., Renard, E., Reznik, Y., Riveline, J.P., Rudoni, S., Schaepelynck, P., Sola-Gazagnes, A., Tubiana-Rufi, N., Verier-Mine, O., Hanaire, H.

Volltext

Prior automatic posture and activity identification improves physical activity energy expenditure prediction from hip-worn triaxial accelerometry von Garnotel, Maël, Bastian, Thomas, Romero-Ugalde, Hector-Manuel, Maire, Aurélia, Dugas, Julien, Zahariev, Alexandre, Doron, Maeva, Jallon, Pierre, Charpentier, Guillaume, Franc, Sylvia, Blanc, Stéphane, Bonnet, Stéphane, Simon, Chantal

Volltext

Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells von Roger, B, Papin, J, Vacher, P, Raoux, M, Mulot, A, Dubois, M, Kerr-Conte, J, Voy, B. H, Pattou, F, Charpentier, G, Jonas, J.-C, Moustaïd-Moussa, N, Lang, J

Volltext

Telemedicine and diabetes: Achievements and prospects von Franc, S, Daoudi, A, Mounier, S, Boucherie, B, Dardari, D, Laroye, H, Neraud, B, Requeda, E, Canipel, L, Charpentier, G

Volltext

Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement von Joubert, M, Baillot-Rudoni, S, Catargi, B, Charpentier, G, Esvant, A, Franc, S, Guerci, B, Guilhem, I, Melki, V, Merlen, E, Penfornis, A, Renard, E, Riveline, J.P, Schaepelynck, P, Sola-Gazagnes, A, Hanaire, H

Volltext

An original piecewise model for computing energy expenditure from accelerometer and heart rate signals von Romero-Ugalde, Hector M, Garnotel, M, Doron, M, Jallon, P, Charpentier, G, Franc, S, Huneker, E, Simon, C, Bonnet, S

Volltext

Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes von Bonnefond, A., Yengo, L., Philippe, J., Dechaume, A., Ezzidi, I., Vaillant, E., Gjesing, A. P., Andersson, E. A., Czernichow, S., Hercberg, S., Hadjadj, S., Charpentier, G., Lantieri, O., Balkau, B., Marre, M., Pedersen, O., Hansen, T., Froguel, P., Vaxillaire, M.

Volltext

Telemedicine and type 1 diabetes: Is technology per se sufficient to improve glycaemic control? von Franc, S, Borot, S, Ronsin, O, Quesada, J.-L, Dardari, D, Fagour, C, Renard, E, Leguerrier, A.-M, Vigeral, C, Moreau, F, Winiszewski, P, Vambergue, A, Mosnier-Pudar, H, Kessler, L, Reffet, S, Guerci, B, Millot, L, Halimi, S, Thivolet, C, Benhamou, P.-Y, Penfornis, A, Charpentier, G, Hanaire, H

Volltext

Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients von Charpentier, G., Fleury, F., Kabir, M., Vaur, L., Halimi, S.

Volltext

Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries von Stone, M.A, Wilkinson, J.C, Charpentier, G, Clochard, N, Grassi, G, Lindblad, U, Müller, U.A, Nolan, J, Rutten, G.E, Khunti, K

Volltext

Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients von Franc, S, Dardari, D, Boucherie, B, Riveline, J.-P, Biedzinski, M, Petit, C, Requeda, E, Leurent, P, Varroud-Vial, M, Hochberg, G, Charpentier, G

Volltext

Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids von Duesing, K, Fatemifar, G, Charpentier, G, Marre, M, Tichet, J, Hercberg, S, Balkau, B, Froguel, P, Gibson, F

Volltext

Type 1 diabetes: Dealing with physical activity von Franc, S, Dardari, D, Biedzinski, M, Requeda, E, Canipel, L, Hochberg, G, Boucherie, B, Charpentier, G

Volltext

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes von Ruiz, J, Morabia, A, Blanche, H, James, R.W, Garin, M-C.B, Charpentier, G, Passa, Ph, Vaisse, C, Ruiz, J, Froguel, Ph

Volltext

Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes von Clement, K, Hercberg, S, Passinge, B, Galan, P, Varroud-Vial, M, Shuldiner, A.R, Beamer, B.A, Charpentier, G, Guy-Grand, B, Froguel, P

Volltext